EdgarLookup

Immix Biopharma, Inc. — DEFA14A Filings

5 DEFA14A filings on record

This page lists all DEFA14A filings submitted to the SEC by Immix Biopharma, Inc. (IMMX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Immix Biopharma, Inc. has filed 5 DEFA14A documents with the SEC since 2021. To view all SEC filings by Immix Biopharma, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 3 4 4/A 424B4 424B5 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DRS DRSLTR EFFECT FWP RW RW WD S-1 S-1/A S-3 S-8 SC 13D SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
DEFA14A DEFA14A 0001641172-25-011516 May 19, 2025 —
DEFA14A DEFA14A 0001641172-25-008447 May 5, 2025 —
DEFA14A — 0001493152-24-020875 May 21, 2024 —
DEFA14A — 0001493152-23-013541 Apr 25, 2023 —
DEFA14A — 0001493152-22-010872 Apr 25, 2022 —